Abacus Medicine Pharma Services ApS — Credit Rating and Financial Key Figures
CVR number: 39192063
Kalvebod Brygge 35, 1560 København V
customerservices@aposave.com
www.aposave.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 212.16 | -63.48 | -43.13 | -36.34 | -72.86 |
| Other operating expenses | -13.20 | ||||
| EBIT | - 212.16 | -63.48 | -43.13 | -49.54 | -72.86 |
| Other financial income | 1 265.32 | 880.92 | 6 147.52 | 3 975.03 | 6 721.74 |
| Other financial expenses | - 351.59 | - 576.01 | -2 541.91 | -9 763.25 | -4 872.10 |
| Pre-tax profit | 701.57 | 241.43 | 3 562.48 | -5 837.77 | 1 776.78 |
| Income taxes | - 153.93 | -53.11 | - 783.75 | 1 284.31 | - 391.24 |
| Net earnings | 547.64 | 188.31 | 2 778.73 | -4 553.46 | 1 385.54 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 5 637.60 | 22 059.99 | 22 059.99 | 22 046.79 | 22 046.79 |
| Investments total | 5 637.60 | 22 059.99 | 22 059.99 | 22 046.79 | 22 046.79 |
| Non-curr. owed by group member comp. | 16 756.06 | 35 749.92 | 64 229.84 | 79 866.01 | 102 889.20 |
| Long term receivables total | 16 756.06 | 35 749.92 | 64 229.84 | 79 866.01 | 102 889.20 |
| Inventories total | |||||
| Current amounts owed by group member comp. | 182.65 | 685.55 | 1 932.98 | 635.92 | 2 245.37 |
| Current deferred tax assets | 500.56 | ||||
| Short term receivables total | 182.65 | 685.55 | 1 932.98 | 1 136.49 | 2 245.37 |
| Cash and bank deposits | 9.96 | 0.00 | 2.67 | 174.25 | |
| Cash and cash equivalents | 9.96 | 0.00 | 2.67 | 174.25 | |
| Balance sheet total (assets) | 22 586.28 | 58 495.47 | 88 225.48 | 103 223.54 | 127 181.36 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Retained earnings | 14 836.19 | 21 883.82 | 22 072.14 | 24 850.87 | 20 297.41 |
| Profit of the financial year | 547.64 | 188.31 | 2 778.73 | -4 553.46 | 1 385.54 |
| Shareholders equity total | 15 883.82 | 22 572.14 | 25 350.87 | 20 797.41 | 22 182.95 |
| Non-current owed to group member | 79 780.95 | 100 828.54 | |||
| Non-current liabilities total | 79 780.95 | 100 828.54 | |||
| Current loans from credit institutions | 0.87 | ||||
| Current trade creditors | 52.99 | 34.50 | 34.50 | 30.00 | 50.00 |
| Current owed to group member | 6 495.53 | 35 834.84 | 62 056.37 | 2 615.18 | 3 728.98 |
| Short-term deferred tax liabilities | 153.93 | 53.11 | 783.75 | 390.89 | |
| Other non-interest bearing current liabilities | -0.00 | ||||
| Current liabilities total | 6 702.46 | 35 923.33 | 62 874.61 | 2 645.18 | 4 169.87 |
| Balance sheet total (liabilities) | 22 586.28 | 58 495.47 | 88 225.48 | 103 223.54 | 127 181.36 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.